WallStSmart

Ecolab Inc (ECL)vsKronos Worldwide Inc (KRO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ecolab Inc generates 765% more annual revenue ($16.08B vs $1.86B). ECL leads profitability with a 12.9% profit margin vs -6.0%. KRO appears more attractively valued with a PEG of 1.36. ECL earns a higher WallStSmart Score of 55/100 (C-).

ECL

Buy

55

out of 100

Grade: C-

Growth: 6.0Profit: 6.5Value: 4.7Quality: 5.8
Piotroski: 3/9Altman Z: 2.30

KRO

Hold

50

out of 100

Grade: D+

Growth: 4.7Profit: 2.0Value: 6.7Quality: 7.5
Piotroski: 3/9Altman Z: 1.60
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ECLSignificantly Overvalued (-142.8%)

Margin of Safety

-142.8%

Fair Value

$125.04

Current Price

$268.54

$143.50 premium

UndervaluedFair: $125.04Overvalued

Intrinsic value data unavailable for KRO.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ECL3 strengths · Avg: 8.7/10
Market CapQuality
$74.91B9/10

Large-cap with strong market position

Return on EquityProfitability
22.5%9/10

Every $100 of equity generates 23 in profit

Revenue GrowthGrowth
17.8%8/10

17.8% revenue growth

KRO2 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

EPS GrowthGrowth
124.8%10/10

Earnings expanding 124.8% YoY

Areas to Watch

ECL4 concerns · Avg: 3.3/10
P/E RatioValuation
36.4x4/10

Premium valuation, high expectations priced in

Price/BookValuation
11.4x4/10

Trading at 11.4x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
2.732/10

Expensive relative to growth rate

KRO4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.604/10

Distress zone — elevated risk

Market CapQuality
$621.29M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-14.1%2/10

ROE of -14.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : ECL

The strongest argument for ECL centers on Market Cap, Return on Equity, Revenue Growth. Revenue growth of 17.8% demonstrates continued momentum.

Bull Case : KRO

The strongest argument for KRO centers on Price/Book, EPS Growth. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bear Case : ECL

The primary concerns for ECL are P/E Ratio, Price/Book, Piotroski F-Score.

Bear Case : KRO

The primary concerns for KRO are Altman Z-Score, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

ECL profiles as a growth stock while KRO is a turnaround play — different risk/reward profiles.

KRO carries more volatility with a beta of 1.07 — expect wider price swings.

ECL is growing revenue faster at 17.8% — sustainability is the question.

ECL generates stronger free cash flow (758M), providing more financial flexibility.

Bottom Line

ECL scores higher overall (55/100 vs 50/100) and 17.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ecolab Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Ecolab Inc., headquartered in St. Paul, Minnesota, is an American corporation that develops and offers services, technology and systems that specialize in water treatment, purification, cleaning and hygiene in a wide variety of applications. It helps organizations both private market as well as public treat their water, not only for drinking directly, but also for use in food, healthcare, hospitality related safety and industry.

Kronos Worldwide Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Kronos Worldwide, Inc. produces and markets titanium dioxide (TiO2) pigments in Europe, North America, Asia Pacific, and internationally. The company is headquartered in Dallas, Texas.

Visit Website →

Want to dig deeper into these stocks?